MSK Fair Value Estimate
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
MSK
Morgan Stanley Capital Trust VIII
DELISTED - Morgan Stanley Capital Trust VIII (the Trust) is a trust that exists solely to issue and sell its common securities to Morgan Stanley, and issues and sells its capital securities to the public. The Trust uses the proceeds from the sale of its common securities and capital securities to purchase junior subordinated debentures from Morgan Stanley, and engages in other activities that are necessary or incidental to these purposes. The Trust holds directly or indirectly all of the common securities of each of the Morgan Stanley Capital Trusts. The junior subordinated debentures will be the Trust's only assets.
Current Price
$25.76
GoodMoat Value
$6.65
74.2% overvaluedBlended fair value estimate based on DCF, Graham Number, and earnings-based models.
Graham Number, PEG-based, and Earnings-based models
View Fair Value →Morgan Stanley Capital Trust VIII (MSK) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The GoodMoat Fair Value target for Morgan Stanley Capital Trust VIII is $6.65. The current stock price is $25.76, suggesting the stock is 287.1% overvalued.
Price-to-book ratio is 45.91.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Morgan Stanley Capital Trust VIII's intrinsic value.